Albiflorin's anti‐AD effects involve activation of the mitogen‐activated protein kinases/extracellular signal‐regulated kinase (MAPK/ERK) signaling pathway, which inhibits neuronal apoptosis. The gene discussed is MAPK1; the disease is Alzheimer disease.